Table 4.
EQ-5D | Model 1 | Model 2 | ||||||
---|---|---|---|---|---|---|---|---|
Mean Difference | 95%CI | p | Mean Difference | 95%CI | p | |||
Lower | Upper | Lower | Upper | |||||
EQ-5D-5L values (Non-Parkinson’s vs. Parkinson’s) | ||||||||
Baseline | 0.13 | 0.10 | 0.17 | <0.001 | 0.15 | 0.12 | 0.18 | <0.001 |
End of study | 0.16 | 0.12 | 0.18 | <0.001 | 0.17 | 0.14 | 0.20 | <0.001 |
EQ VAS scores (Non-Parkinson’s vs. Parkinson’s) | ||||||||
Baseline | 9.25 | 6.56 | 11.95 | <0.001 | 10.18 | 7.40 | 12.96 | <0.001 |
End of study | 11.45 | 8.76 | 14.14 | <0.001 | 12.19 | 9.41 | 14.97 | <0.001 |
Linear mixed model was used to estimate the group differences at baseline and the end of study. In model 1, group of participants, visit, and group*visit are treated as fixed effects and subject as random effect. Model 2 is based on model 1 plus age of participants, gender, education, smoking status, alcoholic drinking status, health condition and life style. CI: Confidence Interval.